Surgical Sutures Market By Product Type (Suturing Devices, Suture Threads [Absorbable And Non Absorbable]), By Suture Type (Natural And Synthetic), By Suture Filament (Monofilament, Multifilament, And Barbed), By Application (General Surgery, Cardiovascular Surgery, Orthopaedic Surgery, Ophthalmic Surgery, Gynaecological Surgery, Others), By End-User (Hospitals, Specialty Clinics, And Ambulatory Surgical Centers), by geography, is expected to grow at a significant CAGR forecast till 2027 owing to the increasing surgical procedures across the globe and launch of advanced surgical sutures in the market
The global surgical sutures market was valued at USD 3.56 billion in 2021, growing at a CAGR of 6.64% during the forecast period from 2022 to 2027, to reach USD 5.24 billion by 2027. The increase in demand for surgical sutures is predominantly attributed to the rise in the volume of surgeries worldwide. Moreover, an increase in various diseases such as arthritis, spinal deformities, cancers, among others which require surgery for their management, a rise in non-fatal injuries, growing approval of products, and launches of various advanced surgical sutures are anticipated to bolster the demand for these sutures thereby leading to an increase in the global market for surgical sutures during the forecasted period.
The market for surgical sutures is gaining momentum at present owing to the increase in surgical procedures across the globe. For instance, as per the data published by the Global Surgery Foundation in the year 2021, there are approximately 30% of global disorders caused by various indications can be treated by surgery.
Furthermore, according to the statistics published by the World Health Organization (WHO) in the year 2021, the rate of caesarean section continues to rise globally accounting for more than 21% of all childbirths. As per the report, the number is anticipated to increase and approximately 29% of all births would likely take place by caesarean section by 2030.
Thus, growing surgeries would contribute to the growth of the overall surgical sutures market in the upcoming years.
In addition, the launch of advanced sutures for an efficient closure of the surgical site is also expected to boost the surgical sutures market in the forthcoming years. For instance, on June 17, 2020, DePuy Synthes, the Johnson & Johnson Medical Devices Companies, launched DYNACORD Suture intended to be used in procedures such as soft tissue approximation in rotator cuff repairs in select European markets. Unlike other high-strength orthopaedic sutures which may experience laxity, DYNACORD Suture is specifically designed to shorten when compression is lost, thereby minimizing gap formation.
Hence, all the above-mentioned factors are projected to augment the market for surgical sutures during the forecasted period.
However, the availability of alternative devices for closing the surgical sites and surgery wounds, and stringent regulatory approval process for the surgical sutures is likely to impede the global surgical sutures market in the upcoming years.
In addition, the unprecedented COVID-19 outbreak has slowed down the global market for surgical sutures during the initial phases. Nationwide lockdown, cancelled or denied elective surgeries to prevent the transmission of the infection, disruptive supply chain due to logistical restriction across the border are some of the reasons that lead to the sluggish market growth of surgical sutures. According to the World Health Organization “pulse survey” published in the year 2021, about 90% of countries are still reporting one or more disruptions to essential health services. Potentially life-saving emergency, critical, and surgical care interventions are still disrupted in about 20% of countries, reflecting the most immediate indirect consequences of the pandemic. Two-thirds of countries also report disruptions in elective surgeries, with accumulating consequences as the pandemic is prolonged. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains including healthcare services, thereby paving the way for a sound period of recovery for the surgical sutures market.
Surgical Sutures Market By Product Type (Suturing Devices, Suture Threads [Absorbable and Non-Absorbable]), By Suture Type (Natural And Synthetic), By Suture Filament (Monofilament, Multifilament, And Barbed), By Application (General Surgery, Cardiovascular Surgery, Orthopaedic Surgery, Ophthalmic Surgery, Gynaecological Surgery, Others), By End-User (Hospitals, Specialty Clinics, And Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the surgical sutures product type segment, the suture thread category accounted for a significant share during the forecasted period. The suture thread is sub-categorized into absorbable and non - absorbable types. The wide availability of absorbable sutures is one of the factors for increased market growth.
In addition, the advantage of providing sufficient tensile strength for wound closure, while dissolving over time has increased their demand.
Moreover, recommendations by the governmental organization for the use of technologically advanced absorbable surgical sutures would also bolster the demand in the upcoming years. For instance, on June 28, 2021, National Institute for Health and Care Excellence (NICE) has issued new medical technologies guidance (MTG) recommending the use of Plus Sutures developed by Ethicon, a medical device division of Johnson & Johnson, in surgeries within the National Health Service (NHS). Plus Sutures are a range of synthetic, absorbable sutures that are either impregnated with or coated with medical-grade triclosan, a broadspectrum antibacterial agent effective on most common organisms associated with surgical site infection (SSI).
Hence the aforementioned factors are likely to contribute to the market growth in the forthcoming years.
Among all the regions, North America is expected to occupy a major share in the overall surgical sutures market during the forecasted period. This domination is owing to the rise in various diseases such as bone deformities, cancer, among others leading to a large population undergoing surgeries thereby fuelling the market for surgical sutures in the region. In addition, the presence of key players such as Johnson & Johnson, DemeTECH Corporation, among others active in the development of surgical sutures, and adoption of technologically advanced surgical sutures by healthcare professionals in the region will also contribute to the surgical sutures market.
For instance, as per the Centers for Disease Control and Prevention 2021 data, in the US, approximately 24% of all adults, or 58.5 million people, have arthritis in 2020. Moreover, as per the annual report released by the American Joint Replacement Registry (AJRR) in the year 2020, as of July 1, 2020, approximately 2 million hip and knee arthroplasty procedures were performed.
Furthermore, as per the Canadian Institute for Health Information 2021 data, in 2019-2020 in Canada, 63,496 hip replacements and 75,073 knee replacements were performed and the demand for both the replacement surgeries continues to increase. Thus, the rise in surgeries as a treatment option for the various disorders would contribute to the surgical sutures market.
Moreover, approval of surgical sutures in the region is also one of the factors responsible for the growth of the surgical sutures during the forecasted period. For instance, in July 2020, SM ENG CO., LTD, received the US FDA approval for its surgical suture, REXSIN (a synthetic absorbable PGA suture) indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures.
Also, in October 2020, FDA gave clearance to StitchKit PARK, a device that enables surgeons to customize the contents of its StitchKit suture-delivery device with the sutures of their choice developed by Origami Surgical.
Thus, the interplay of all the factors in the region is expected to propel the regional surgical sutures market in the forthcoming years.
Additionally, the Asia-pacific region has the future potential for the surgical sutures market. This is due to the rising number of surgeries such as cardiac surgery, caesarean surgery, among others in the region. For instance, as per the 2019 statistics revealed by the Australian Institute of Health and Welfare, about 24% (2.7 million) of the hospital admissions in the country involved elective surgery in the year 2017-2018. Furthermore, improving healthcare structure, rise in disposable incomes, and presence of regional market players such as Gunze Limited, Meril Lifesciences, among others will also contribute to the market growth of surgical sutures in the forthcoming years.
Some of the key market players operating in the Surgical Sutures market include Johnson & Johnson, Medtronic, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmacéutica S.A . de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated., Lotus Surgicals., CONMED Corporation., Unisur Lifecare Pvt. Ltd., GUNZE LIMITED., Sutcon Sutures, Bydand Medical, MANI, INC., Samyang Holdings Corporation, META BIOMED CO,. LTD., Healthium Medtech Limited, Dolphin Sutures., ORIGAMI SURGICAL LLC, and others.
1. What are Surgical Sutures?
A surgical suture is one of the most common medical devices used by doctors during surgeries. The suture helps in holding body tissues together after a surgery or an injury. The application of a suture essentially involves the use of a needle along with an attached thread.
2. What is the market for Global Surgical Sutures?
The global surgical sutures market was valued at USD 3.56 billion in 2021, growing at a CAGR of 6.64% during the forecast period from 2022 to 2027, to reach USD 5.24 billion by 2027.
3. What are the drivers for the Global Surgical Sutures?
The major factors driving the demand for Surgical Sutures are the rising surgical procedures across the globe. In addition, an increase in diseases such as coronary artery diseases, neurovascular disorders, among others which require surgical intervention, a rise in falls and injuries, the launch of various advanced surgical sutures, among others are likely to drive the market during the forecasted period.
4. What are the key players operating in Global Surgical Sutures?
Some of the key market players operating in the Surgical Sutures market include Johnson & Johnson, Medtronic, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmacéutica S.A . de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated., Lotus Surgicals., CONMED Corporation., Unisur Lifecare Pvt. Ltd., GUNZE LIMITED., Sutcon Sutures, Bydand Medical, MANI, INC., Samyang Holdings Corporation, META BIOMED CO,. LTD., Healthium Medtech Limited, Dolphin Sutures., and others.
5. Which region has the highest share in the Surgical Sutures market?
Among all the regions, North America is expected to occupy a major share in the overall surgical sutures market during the forecasted period, 2022-2027. This domination is owing to the rise in chronic diseases leading to a large population undergoing surgeries thereby fuelling the market for surgical sutures in the region. In addition, the presence of key players such as Johnson & Johnson, DemeTECH Corporation, among others active in the development of surgical sutures, and adoption of technologically advanced surgical sutures by healthcare professionals in the region will also contribute to the surgical sutures market.
This product will be updated with the latest data at the time of order. Consequently, dispatch time for this product will be 7-10 business days.
The global surgical sutures market was valued at USD 3.56 billion in 2021, growing at a CAGR of 6.64% during the forecast period from 2022 to 2027, to reach USD 5.24 billion by 2027. The increase in demand for surgical sutures is predominantly attributed to the rise in the volume of surgeries worldwide. Moreover, an increase in various diseases such as arthritis, spinal deformities, cancers, among others which require surgery for their management, a rise in non-fatal injuries, growing approval of products, and launches of various advanced surgical sutures are anticipated to bolster the demand for these sutures thereby leading to an increase in the global market for surgical sutures during the forecasted period.
Surgical Sutures Market Dynamics:
The market for surgical sutures is gaining momentum at present owing to the increase in surgical procedures across the globe. For instance, as per the data published by the Global Surgery Foundation in the year 2021, there are approximately 30% of global disorders caused by various indications can be treated by surgery.
Furthermore, according to the statistics published by the World Health Organization (WHO) in the year 2021, the rate of caesarean section continues to rise globally accounting for more than 21% of all childbirths. As per the report, the number is anticipated to increase and approximately 29% of all births would likely take place by caesarean section by 2030.
Thus, growing surgeries would contribute to the growth of the overall surgical sutures market in the upcoming years.
In addition, the launch of advanced sutures for an efficient closure of the surgical site is also expected to boost the surgical sutures market in the forthcoming years. For instance, on June 17, 2020, DePuy Synthes, the Johnson & Johnson Medical Devices Companies, launched DYNACORD Suture intended to be used in procedures such as soft tissue approximation in rotator cuff repairs in select European markets. Unlike other high-strength orthopaedic sutures which may experience laxity, DYNACORD Suture is specifically designed to shorten when compression is lost, thereby minimizing gap formation.
Hence, all the above-mentioned factors are projected to augment the market for surgical sutures during the forecasted period.
However, the availability of alternative devices for closing the surgical sites and surgery wounds, and stringent regulatory approval process for the surgical sutures is likely to impede the global surgical sutures market in the upcoming years.
In addition, the unprecedented COVID-19 outbreak has slowed down the global market for surgical sutures during the initial phases. Nationwide lockdown, cancelled or denied elective surgeries to prevent the transmission of the infection, disruptive supply chain due to logistical restriction across the border are some of the reasons that lead to the sluggish market growth of surgical sutures. According to the World Health Organization “pulse survey” published in the year 2021, about 90% of countries are still reporting one or more disruptions to essential health services. Potentially life-saving emergency, critical, and surgical care interventions are still disrupted in about 20% of countries, reflecting the most immediate indirect consequences of the pandemic. Two-thirds of countries also report disruptions in elective surgeries, with accumulating consequences as the pandemic is prolonged. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains including healthcare services, thereby paving the way for a sound period of recovery for the surgical sutures market.
Surgical Sutures Market Segment Analysis:
Surgical Sutures Market By Product Type (Suturing Devices, Suture Threads [Absorbable and Non-Absorbable]), By Suture Type (Natural And Synthetic), By Suture Filament (Monofilament, Multifilament, And Barbed), By Application (General Surgery, Cardiovascular Surgery, Orthopaedic Surgery, Ophthalmic Surgery, Gynaecological Surgery, Others), By End-User (Hospitals, Specialty Clinics, And Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the surgical sutures product type segment, the suture thread category accounted for a significant share during the forecasted period. The suture thread is sub-categorized into absorbable and non - absorbable types. The wide availability of absorbable sutures is one of the factors for increased market growth.
In addition, the advantage of providing sufficient tensile strength for wound closure, while dissolving over time has increased their demand.
Moreover, recommendations by the governmental organization for the use of technologically advanced absorbable surgical sutures would also bolster the demand in the upcoming years. For instance, on June 28, 2021, National Institute for Health and Care Excellence (NICE) has issued new medical technologies guidance (MTG) recommending the use of Plus Sutures developed by Ethicon, a medical device division of Johnson & Johnson, in surgeries within the National Health Service (NHS). Plus Sutures are a range of synthetic, absorbable sutures that are either impregnated with or coated with medical-grade triclosan, a broadspectrum antibacterial agent effective on most common organisms associated with surgical site infection (SSI).
Hence the aforementioned factors are likely to contribute to the market growth in the forthcoming years.
North America is expected to dominate the overall Surgical Sutures Market:
Among all the regions, North America is expected to occupy a major share in the overall surgical sutures market during the forecasted period. This domination is owing to the rise in various diseases such as bone deformities, cancer, among others leading to a large population undergoing surgeries thereby fuelling the market for surgical sutures in the region. In addition, the presence of key players such as Johnson & Johnson, DemeTECH Corporation, among others active in the development of surgical sutures, and adoption of technologically advanced surgical sutures by healthcare professionals in the region will also contribute to the surgical sutures market.
For instance, as per the Centers for Disease Control and Prevention 2021 data, in the US, approximately 24% of all adults, or 58.5 million people, have arthritis in 2020. Moreover, as per the annual report released by the American Joint Replacement Registry (AJRR) in the year 2020, as of July 1, 2020, approximately 2 million hip and knee arthroplasty procedures were performed.
Furthermore, as per the Canadian Institute for Health Information 2021 data, in 2019-2020 in Canada, 63,496 hip replacements and 75,073 knee replacements were performed and the demand for both the replacement surgeries continues to increase. Thus, the rise in surgeries as a treatment option for the various disorders would contribute to the surgical sutures market.
Moreover, approval of surgical sutures in the region is also one of the factors responsible for the growth of the surgical sutures during the forecasted period. For instance, in July 2020, SM ENG CO., LTD, received the US FDA approval for its surgical suture, REXSIN (a synthetic absorbable PGA suture) indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures.
Also, in October 2020, FDA gave clearance to StitchKit PARK, a device that enables surgeons to customize the contents of its StitchKit suture-delivery device with the sutures of their choice developed by Origami Surgical.
Thus, the interplay of all the factors in the region is expected to propel the regional surgical sutures market in the forthcoming years.
Additionally, the Asia-pacific region has the future potential for the surgical sutures market. This is due to the rising number of surgeries such as cardiac surgery, caesarean surgery, among others in the region. For instance, as per the 2019 statistics revealed by the Australian Institute of Health and Welfare, about 24% (2.7 million) of the hospital admissions in the country involved elective surgery in the year 2017-2018. Furthermore, improving healthcare structure, rise in disposable incomes, and presence of regional market players such as Gunze Limited, Meril Lifesciences, among others will also contribute to the market growth of surgical sutures in the forthcoming years.
Surgical Sutures Market Key Players:
Some of the key market players operating in the Surgical Sutures market include Johnson & Johnson, Medtronic, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmacéutica S.A . de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated., Lotus Surgicals., CONMED Corporation., Unisur Lifecare Pvt. Ltd., GUNZE LIMITED., Sutcon Sutures, Bydand Medical, MANI, INC., Samyang Holdings Corporation, META BIOMED CO,. LTD., Healthium Medtech Limited, Dolphin Sutures., ORIGAMI SURGICAL LLC, and others.
Recent Developmental Activities in the Surgical Sutures Market:
- On November 24, 2020, Healthium Medtech Limited launched TRUBARB, an absorbable surgical needled suture and a polydioxanone knotless tissue-closure device with a triangular end-stopper.
- On November 24, 2020, LSI Solutions, Inc. received FDA approval for RAM® COR-SUTURE® QUICK LOAD® Surgical Suture and COR-SUTURE® QUICK LOAD® Surgical Suture intended for use in the approximation of soft tissue and prosthetic materials.
- On September 09, 2020, Smith+Nephew launched HEALICOIL™ KNOTLESS Suture Anchor, expanding its revolutionary line of Advanced Healing Solutions for rotator cuff repair.
Key Takeaways from the Surgical Sutures Market Report Study
- Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Surgical Sutures market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the Global Surgical Sutures Market.
- Various opportunities available for the other competitor in the Surgical Sutures Market space.
- What are the top-performing segments in 2021? How these segments will perform in 2027.
- Which are the top-performing regions and countries in the current market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Surgical Sutures market growth in the coming future?
Target Audience who can be benefited from the Surgical Sutures Market Report Study
- Surgical Sutures providers
- Research organizations and consulting companies
- Surgical Sutures-related organization, association, forum, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders in Surgical Sutures
- Various End-users who want to know more about the Surgical Sutures Market and the latest technological developments in the Surgical Sutures market.
Frequently Asked Questions for the Surgical Sutures Market:
1. What are Surgical Sutures?
A surgical suture is one of the most common medical devices used by doctors during surgeries. The suture helps in holding body tissues together after a surgery or an injury. The application of a suture essentially involves the use of a needle along with an attached thread.
2. What is the market for Global Surgical Sutures?
The global surgical sutures market was valued at USD 3.56 billion in 2021, growing at a CAGR of 6.64% during the forecast period from 2022 to 2027, to reach USD 5.24 billion by 2027.
3. What are the drivers for the Global Surgical Sutures?
The major factors driving the demand for Surgical Sutures are the rising surgical procedures across the globe. In addition, an increase in diseases such as coronary artery diseases, neurovascular disorders, among others which require surgical intervention, a rise in falls and injuries, the launch of various advanced surgical sutures, among others are likely to drive the market during the forecasted period.
4. What are the key players operating in Global Surgical Sutures?
Some of the key market players operating in the Surgical Sutures market include Johnson & Johnson, Medtronic, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmacéutica S.A . de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated., Lotus Surgicals., CONMED Corporation., Unisur Lifecare Pvt. Ltd., GUNZE LIMITED., Sutcon Sutures, Bydand Medical, MANI, INC., Samyang Holdings Corporation, META BIOMED CO,. LTD., Healthium Medtech Limited, Dolphin Sutures., and others.
5. Which region has the highest share in the Surgical Sutures market?
Among all the regions, North America is expected to occupy a major share in the overall surgical sutures market during the forecasted period, 2022-2027. This domination is owing to the rise in chronic diseases leading to a large population undergoing surgeries thereby fuelling the market for surgical sutures in the region. In addition, the presence of key players such as Johnson & Johnson, DemeTECH Corporation, among others active in the development of surgical sutures, and adoption of technologically advanced surgical sutures by healthcare professionals in the region will also contribute to the surgical sutures market.
This product will be updated with the latest data at the time of order. Consequently, dispatch time for this product will be 7-10 business days.
Table of Contents
1. Surgical Sutures Market Report Introduction6. COVID-19 Impact Analysis on Surgical Sutures Market8. Surgical Sutures Global Company Share Analysis - Key 3-5 Companies10. KOL Views11. Project Approach12. About the Publisher13. Disclaimer & Contact the Publisher
2. Surgical Sutures Market Executive summary
3. Regulatory and Patent Analysis
4. Surgical Sutures Market Key factors analysis
5. Surgical Sutures Porter's Five Forces Analysis
7. Surgical Sutures Market layout
9. Surgical Sutures Company and Product Profiles
List of Tables
List of Figures
